GeneTex

  • Country / Location Selection

United States (US)

TTC8 blocking peptide

Cat. No. GTX88117-PEP

Species

 Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX88117.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-KEVLKQDNTHVE

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Tetratricopeptide Repeat Domain 8 , Bbs8 , Rp51 , Ttc8

Background

This gene encodes a protein that has been directly linked to Bardet-Biedl syndrome. The primary features of this syndrome include retinal dystrophy, obesity, polydactyly, renal abnormalities and learning disabilities. Experimentation in non-human eukaryotes suggests that this gene is expressed in ciliated cells and that it is involved in the formation of cilia. Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for TTC8 blocking peptide (GTX88117-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for TTC8 blocking peptide (GTX88117-PEP). Be the first to share your experience with this product.
Submit a Review
Package List Price ($)
$ 239